Wordt geladen...

Triptolide reverses the Taxol resistance of lung adenocarcinoma by inhibiting the NF-κB signaling pathway and the expression of NF-κB-regulated drug-resistant genes

Paclitaxel (or Taxol(®)) is a first-line chemotherapeutic drug for the treatment of non-small cell lung cancer; however, resistance to the drug is an important factor, which influences the outcome of chemotherapy. The present study aimed to investigate the role of triptolide (TPL) in reversing Taxol...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Mol Med Rep
Hoofdauteurs: JIANG, NING, DONG, XIAO-PENG, ZHANG, SUO-LIN, YOU, QING-YONG, JIANG, XING-TAO, ZHAO, XIAO-GANG
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: D.A. Spandidos 2016
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4686042/
https://ncbi.nlm.nih.gov/pubmed/26531258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2015.4493
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!